← Leaderboards
David J Volsky
St. Luke'S-Roosevelt Inst For Hlth Scis
$39,337,604
Attributed
$69,963,455
Total exposure
24
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$80,904,096 · 25
By mechanism
R01$35,743,284 · 11
U01$25,602,575 · 2
P01$13,674,088 · 3
RF1$2,475,013 · 1
R21$2,289,792 · 5
R56$868,544 · 1
Top collaborators
- Mary Jane Potash19 shared
- Joan Weinberger Berman10 shared
- Jennifer L Kelschenbach9 shared
- Paul J Kenny9 shared
- Alejandra Borjabad5 shared
- Mohamed Abdel Mohsen4 shared
- Lishomwa C Ndhlovu4 shared
- Hongkui Zeng4 shared
Most similar at St. Luke'S-Roosevelt Inst For Hlth Scis
Same institution · by research overlap
- Jennifer L Kelschenbach$2,364,977
- Mary Jane Potash$12,977,842
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainCellsHiv InfectionsInfectionChronicVirusAntiretroviral TherapyBrain DiseasesMacrophageGenesGene ExpressionMouse ModelBrain TissueImpaired CognitionResponseNeurocognitive DeficitInflammationBrain CellMediatingNeuropathogenesisPharmaceutical PreparationsBaseImmunocompetentNeuropathology
Grant awards (109)
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration$3,657,715
U01 · FY2025 · DA
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice$1,641,558
U01 · FY2025 · DA
Routes to Enhanced HIV Neuropathogenesis Through Expression of Subclinical Levels of Endogenous Amyloid-Beta$827,685
R01 · FY2025 · NS · contact PI
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$754,025
R01 · FY2025 · DA
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration$3,653,101
U01 · FY2024 · DA
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice$1,641,558
U01 · FY2024 · DA
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$754,413
R01 · FY2024 · DA
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice$705,462
R01 · FY2024 · DA · contact PI
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration$3,648,488
U01 · FY2023 · DA
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice$2,506,585
U01 · FY2023 · DA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,815
R01 · FY2023 · NS
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$761,502
R01 · FY2023 · DA
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice$705,462
R01 · FY2023 · DA · contact PI
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration$3,557,665
U01 · FY2022 · DA
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice$2,641,224
U01 · FY2022 · DA
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta$2,475,013
RF1 · FY2022 · NS · contact PI
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$847,023
R01 · FY2022 · NS
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$785,684
R01 · FY2022 · DA
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice$720,231
R01 · FY2022 · DA · contact PI
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice$2,654,681
U01 · FY2021 · DA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,928
R01 · FY2021 · NS
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice$720,231
R01 · FY2021 · DA · contact PI
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$716,442
R01 · FY2021 · DA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$907,453
R01 · FY2020 · NS
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta$868,544
R56 · FY2020 · NS · contact PI
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$719,921
R01 · FY2020 · DA
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2020 · NS
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice$701,110
R01 · FY2020 · DA · contact PI
Reversal of HIV Cognitive Disease in Mice Employing Broadly Specific T Cell Vaccines$84,750
R03 · FY2020 · NS
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$723,314
R01 · FY2019 · DA
Toward control of HIV neuropathogenesis by innate immunity$706,571
R01 · FY2019 · NS
Reversal of HIV Cognitive Disease in Mice Employing Broadly Specific T Cell Vaccines$84,750
R03 · FY2019 · NS
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine$791,843
R01 · FY2018 · DA · contact PI
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2018 · NS
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$678,042
R01 · FY2018 · MH · contact PI
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$586,232
R01 · FY2018 · DA
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$140,389
R01 · FY2018 · DA
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine$791,843
R01 · FY2017 · DA · contact PI
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse$730,959
R01 · FY2017 · DA
Toward control of HIV neuropathogenesis by innate immunity$706,571
R01 · FY2017 · NS
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$678,042
R01 · FY2017 · MH · contact PI
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine$783,926
R01 · FY2016 · DA · contact PI
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2016 · NS
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$678,042
R01 · FY2016 · MH · contact PI
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine$839,533
R01 · FY2015 · DA · contact PI
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$700,925
R01 · FY2015 · MH · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$661,947
R01 · FY2015 · DA · contact PI
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine$805,969
R01 · FY2014 · DA · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$624,490
R01 · FY2014 · DA · contact PI
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$515,016
R01 · FY2014 · MH · contact PI
CNS Reservoirs of HIV in a Mouse Model of HIV Infection and Cognitive Impairment:$174,935
R01 · FY2014 · MH · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$634,314
R01 · FY2013 · DA · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$98,594
R01 · FY2013 · DA · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$662,163
R01 · FY2012 · DA · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$469,674
R01 · FY2012 · MH · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$599,908
R01 · FY2011 · DA · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$471,010
R01 · FY2011 · MH · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$477,160
R01 · FY2010 · MH · contact PI
Overexpression of Complement in the Brain and HIV Neuropathogenesis$243,900
R21 · FY2010 · MH · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$227,841
R01 · FY2010 · MH · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$479,594
R01 · FY2009 · MH · contact PI
NeuroAIDS Therapy in the EcoHIV Mouse Model$243,900
R21 · FY2009 · NS · contact PI
Overexpression of Complement in the Brain and HIV Neuropathogenesis$203,250
R21 · FY2009 · MH · contact PI
NeuroAIDS Therapy in the EcoHIV Mouse Model$157,716
R21 · FY2009 · NS · contact PI
Mouse Model of HIV-1 Infection and Drug Addiction$598,952
R01 · FY2008 · DA · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$481,627
R01 · FY2008 · MH · contact PI
NeuroAIDS Therapy in the EcoHIV Mouse Model$203,250
R21 · FY2008 · NS · contact PI
Molecular Mechanisms of HIV-1 Associated Encephalopathy$1,551,345
P01 · FY2007 · NS · contact PI
Mouse Model of HIV-1 Infection and Drug Addiction$595,743
R01 · FY2007 · DA · contact PI
Administrative$221,621
P01 · FY2007 · NS · contact PI
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions$221,621
P01 · FY2007 · NS · contact PI
Role of gp120 in Neuropathogenesis in a New Model of HIV Infection in Mice$211,571
R21 · FY2007 · NS · contact PI
Molecular Mechanisms of HIV-1 Associated Encephalopathy$1,538,559
P01 · FY2006 · NS · contact PI
Mouse Model of HIV-1 Infection and Drug Addiction$598,105
R01 · FY2006 · DA · contact PI
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions$225,083
P01 · FY2006 · NS · contact PI
Administrative$225,083
P01 · FY2006 · NS · contact PI
Role of gp120 in Neuropathogenesis in a New Model of HIV Infection in Mice$181,575
R21 · FY2006 · NS · contact PI
Effect of morphine on HIV-1 neuroinvasion and brain changes in mice$81,300
R03 · FY2006 · DA · contact PI
Molecular Mechanisms of HIV-1 Associated Encephalopathy$1,529,959
P01 · FY2005 · NS
Mouse Model of HIV-1 Infection and Drug Addiction$516,455
R01 · FY2005 · DA
Administrative$218,565
P01 · FY2005 · NS
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions$218,565
P01 · FY2005 · NS
Mouse Model of HIV-1 Infection and Drug Addiction$80,700
R01 · FY2005 · DA
Molecular Mechanisms of HIV-1 Associated Encephalopathy$1,487,483
P01 · FY2004 · NS
Mouse Model of HIV-1 Infection and Drug Addiction$492,805
R01 · FY2004 · DA
Mechanism of action of HIV-1 Vif$348,750
R01 · FY2004 · AI
Administrative$212,497
P01 · FY2004 · NS
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions$212,497
P01 · FY2004 · NS
Molecular Mechanisms of HIV-1 Associated Encephalopathy$1,504,124
P01 · FY2003 · NS
Mechanism of action of HIV-1 Vif$348,750
R01 · FY2003 · AI
Administrative$214,874
P01 · FY2003 · NS
HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions$214,874
P01 · FY2003 · NS
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY$1,085,710
P01 · FY2002 · NS
Mechanism of action of HIV-1 Vif$348,750
R01 · FY2002 · AI
Toward a mouse model of HIV infection &drug addiction$218,772
R21 · FY2002 · DA
Toward a mouse model of HIV infection &drug addiction$95,840
R21 · FY2002 · DA
NEUROTROPIC HIV-1 IN ADULTS AND CHILDREN AND ITS EFFECT ON ASTROCYTE FUNCTION$0
P01 · FY2002 · NS
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY$1,059,470
P01 · FY2001 · NS
Toward a mouse model of HIV infection &drug addiction$181,268
R21 · FY2001 · DA
Mechanism of action of HIV-1 Vif$174,375
R01 · FY2001 · AI
NEUROTROPIC HIV-1 IN ADULTS AND CHILDREN AND ITS EFFECT ON ASTROCYTE FUNCTION$173,158
P01 · FY2001 · NS
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY$100,000
P01 · FY2001 · NS
NEUROTROPIC HIV-1 IN ADULTS AND CHILDREN AND ITS EFFECT ON ASTROCYTE FUNCTION$0
P01 · FY2001 · NS
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY$1,033,991
P01 · FY2000 · NS
MECHANISM OF ACTION OF HIV-1 VIF$348,750
R21 · FY2000 · AI
HIV-1 INFECTION AND EXPRESSION IN MACROPHAGES$254,815
R01 · FY2000 · HL
NEUROTROPIC HIV-1 IN ADULTS AND CHILDREN AND ITS EFFECT ON ASTROCYTE FUNCTION$201,851
P01 · FY2000 · NS
NEUROTROPIC HIV-1 IN ADULTS AND CHILDREN AND ITS EFFECT ON ASTROCYTE FUNCTION$173,158
P01 · FY2000 · NS
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY$50,000
P01 · FY2000 · NS